{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:14:58Z","timestamp":1790712898383,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01411-z","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T20:14:13Z","timestamp":1742674453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chronic Neurological Complications of Brain Tumors and Brain Tumor Treatments"],"prefix":"10.1007","volume":"25","author":[{"given":"Jigisha P.","family":"Thakkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego D.","family":"Luy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Refaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram C.","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"issue":"8","key":"1411_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11910-020-01056-0","volume":"20","author":"JP Thakkar","year":"2020","unstructured":"Thakkar JP, Prabhu VC, Rouse S, Lukas RV. Acute neurological complications of brain tumors and immune therapies, a guideline for the Neuro-hospitalist. Curr Neurol Neurosci Rep. 2020;20(8):32.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2 Suppl 2","key":"1411_CR2","first-page":"7","volume":"17","author":"C Benedetti","year":"2003","unstructured":"Benedetti C. Supportive care in cancer: a general overview. Oncol (Williston Park). 2003;17(2 Suppl 2):7\u20138.","journal-title":"Oncol (Williston Park)"},{"issue":"1","key":"1411_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneurol.2016.185","volume":"13","author":"MT Makale","year":"2017","unstructured":"Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017;13(1):52\u201364.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1411_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1200\/JCO.2004.05.128","volume":"22","author":"CA Meyers","year":"2004","unstructured":"Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157\u201365.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1411_CR5","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/neuonc\/noz068","volume":"21","author":"S Acharya","year":"2019","unstructured":"Acharya S, Wu S, Ashford JM, Tinkle CL, Lucas JT, Qaddoumi I, et al. Association between hippocampal dose and memory in survivors of childhood or adolescent low-grade glioma: a 10-year neurocognitive longitudinal study. Neuro Oncol. 2019;21(9):1175\u201383.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1411_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, et al. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial. JAMA. 2016;316(4):401\u20139.","journal-title":"JAMA"},{"issue":"11","key":"1411_CR7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037\u201344.","journal-title":"Lancet Oncol"},{"issue":"12","key":"1411_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1634\/theoncologist.2008-0130","volume":"13","author":"J Dietrich","year":"2008","unstructured":"Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13(12):1285\u201395.","journal-title":"Oncologist"},{"issue":"3","key":"1411_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11910-012-0264-9","volume":"12","author":"JS Wefel","year":"2012","unstructured":"Wefel JS, Schagen SB. Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012;12(3):267\u201375.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"1411_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.bbr.2011.05.012","volume":"227","author":"M Monje","year":"2012","unstructured":"Monje M, Dietrich J. Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis. Behav Brain Res. 2012;227(2):376\u20139.","journal-title":"Behav Brain Res"},{"issue":"9","key":"1411_CR11","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/nm749","volume":"8","author":"ML Monje","year":"2002","unstructured":"Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces neural precursor-cell dysfunction. Nat Med. 2002;8(9):955\u201362.","journal-title":"Nat Med"},{"issue":"3","key":"1411_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1634\/stemcells.2008-0732","volume":"27","author":"NA Hellstrom","year":"2009","unstructured":"Hellstrom NA, Bjork-Eriksson T, Blomgren K, Kuhn HG. Differential recovery of neural stem cells in the subventricular zone and dentate gyrus after ionizing radiation. Stem Cells. 2009;27(3):634\u201341.","journal-title":"Stem Cells"},{"issue":"5651","key":"1411_CR13","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1088417","volume":"302","author":"ML Monje","year":"2003","unstructured":"Monje ML, Toda H, Palmer TD. Inflammatory Blockade restores adult hippocampal neurogenesis. Science. 2003;302(5651):1760\u20135.","journal-title":"Science"},{"issue":"7","key":"1411_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/jbiol50","volume":"5","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Han R, Yang Y, Mayer-Proschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006;5(7):22.","journal-title":"J Biol"},{"issue":"808","key":"1411_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1259\/0007-1285-68-808-406","volume":"68","author":"GM Morris","year":"1995","unstructured":"Morris GM, Hopewell JW, Morris AD. A comparison of the effects of methotrexate and misonidazole on the germinal cells of the subependymal plate of the rat. Br J Radiol. 1995;68(808):406\u201312.","journal-title":"Br J Radiol"},{"issue":"3","key":"1411_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/ana.20185","volume":"56","author":"W Rzeski","year":"2004","unstructured":"Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, et al. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004;56(3):351\u201360.","journal-title":"Ann Neurol"},{"key":"1411_CR17","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1016\/j.wneu.2018.01.213","volume":"113","author":"J Muto","year":"2018","unstructured":"Muto J, Dezamis E, Rigaux-Viode O, Peeters S, Roux A, Zanello M, et al. Functional-Based resection does not worsen quality of life in patients with a diffuse Low-Grade glioma involving eloquent brain regions: A prospective cohort study. World Neurosurg. 2018;113:e200\u201312.","journal-title":"World Neurosurg"},{"issue":"6","key":"1411_CR18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3171\/2019.3.JNS19211","volume":"132","author":"K Motomura","year":"2020","unstructured":"Motomura K, Chalise L, Ohka F, Aoki K, Tanahashi K, Hirano M, et al. Neurocognitive and functional outcomes in patients with diffuse frontal lower-grade gliomas undergoing intraoperative awake brain mapping. J Neurosurg. 2020;132(6):1683\u201391.","journal-title":"J Neurosurg"},{"issue":"10","key":"1411_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jamaoncol.2017.0997","volume":"3","author":"R Jalali","year":"2017","unstructured":"Jalali R, Gupta T, Goda JS, Goswami S, Shah N, Dutta D, et al. Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and Low-Grade brain tumors: A randomized clinical trial. JAMA Oncol. 2017;3(10):1368\u201376.","journal-title":"JAMA Oncol"},{"key":"1411_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fonc.2019.00991","volume":"9","author":"J Jaspers","year":"2019","unstructured":"Jaspers J, Mendez Romero A, van den Hoogeman MS, Wiggenraad RGJ, Taphoorn MJB, et al. Evaluation of the hippocampal normal tissue complication model in a prospective cohort of low grade glioma Patients-An analysis within the EORTC 22033 clinical trial. Front Oncol. 2019;9:991.","journal-title":"Front Oncol"},{"issue":"4","key":"1411_CR21","doi-asserted-by":"publisher","first-page":"e487","DOI":"10.1016\/j.ijrobp.2011.10.021","volume":"83","author":"V Gondi","year":"2012","unstructured":"Gondi V, Hermann BP, Mehta MP, Tome WA. Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys. 2012;83(4):e487\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1411_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/neuonc\/noaa076","volume":"22","author":"JS Goda","year":"2020","unstructured":"Goda JS, Dutta D, Krishna U, Goswami S, Kothavade V, Kannan S, et al. Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors. Neuro Oncol. 2020;22(11):1677\u201385.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1411_CR23","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/neuonc\/not114","volume":"15","author":"PD Brown","year":"2013","unstructured":"Brown PD, Pugh S, Laack NN, Wefel JS, Khuntia D, Meyers C, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol. 2013;15(10):1429\u201337.","journal-title":"Neuro Oncol"},{"issue":"34","key":"1411_CR24","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1200\/JCO.2014.57.2909","volume":"32","author":"V Gondi","year":"2014","unstructured":"Gondi V, Pugh SL, Tome WA, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32(34):3810\u20136.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1411_CR25","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, et al. Hippocampal avoidance during Whole-Brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol. 2020;38(10):1019\u201329.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1411_CR26","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/neuonc\/noab040","volume":"23","author":"PD Brown","year":"2021","unstructured":"Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, et al. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma. Neuro Oncol. 2021;23(8):1337\u201347.","journal-title":"Neuro Oncol"},{"issue":"15","key":"1411_CR27","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1200\/JCO.2014.58.4508","volume":"33","author":"SR Rapp","year":"2015","unstructured":"Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, et al. Donepezil for irradiated brain tumor survivors: A phase III randomized Placebo-Controlled clinical trial. J Clin Oncol. 2015;33(15):1653\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1411_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-015-2035-3","volume":"127","author":"DD Correa","year":"2016","unstructured":"Correa DD, Kryza-Lacombe M, Baser RE, Beal K, DeAngelis LM. Cognitive effects of donepezil therapy in patients with brain tumors: a pilot study. J Neurooncol. 2016;127(2):313\u20139.","journal-title":"J Neurooncol"},{"issue":"7","key":"1411_CR29","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1200\/JCO.1998.16.7.2522","volume":"16","author":"CA Meyers","year":"1998","unstructured":"Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16(7):2522\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1411_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-011-0723-1","volume":"107","author":"K Gehring","year":"2012","unstructured":"Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, et al. A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012;107(1):165\u201374.","journal-title":"J Neurooncol"},{"issue":"6","key":"1411_CR31","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/CCO.0000000000000581","volume":"31","author":"MB van der Coomans","year":"2019","unstructured":"van der Coomans MB, Gehring K, Taphoorn MJB. Treatment of cognitive deficits in brain tumour patients: current status and future directions. Curr Opin Oncol. 2019;31(6):540\u20137.","journal-title":"Curr Opin Oncol"},{"issue":"1","key":"1411_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11060-009-0006-2","volume":"97","author":"MR Hassler","year":"2010","unstructured":"Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, et al. Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol. 2010;97(1):109\u201315.","journal-title":"J Neurooncol"},{"issue":"1","key":"1411_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11060-013-1153-z","volume":"114","author":"C Zucchella","year":"2013","unstructured":"Zucchella C, Capone A, Codella V, De Nunzio AM, Vecchione C, Sandrini G, et al. Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: a randomized, controlled trial. J Neurooncol. 2013;114(1):93\u2013100.","journal-title":"J Neurooncol"},{"issue":"2","key":"1411_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11060-015-1933-8","volume":"125","author":"M Maschio","year":"2015","unstructured":"Maschio M, Dinapoli L, Fabi A, Giannarelli D, Cantelmi T. Cognitive rehabilitation training in patients with brain tumor-related epilepsy and cognitive deficits: a pilot study. J Neurooncol. 2015;125(2):419\u201326.","journal-title":"J Neurooncol"},{"issue":"3","key":"1411_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11060-019-03130-1","volume":"142","author":"NM Richard","year":"2019","unstructured":"Richard NM, Bernstein LJ, Mason WP, Laperriere N, Maurice C, Millar BA, et al. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial. J Neurooncol. 2019;142(3):565\u201375.","journal-title":"J Neurooncol"},{"issue":"5","key":"1411_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/pon.1577","volume":"19","author":"SL Sanders","year":"2010","unstructured":"Sanders SL, Bantum EO, Owen JE, Thornton AA, Stanton AL. Supportive care needs in patients with lung cancer. Psychooncology. 2010;19(5):480\u20139.","journal-title":"Psychooncology"},{"issue":"3","key":"1411_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11060-005-7020-9","volume":"76","author":"PD Brown","year":"2006","unstructured":"Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76(3):283\u201391.","journal-title":"J Neurooncol"},{"issue":"5","key":"1411_CR38","first-page":"921","volume":"26","author":"MP Lovely","year":"1999","unstructured":"Lovely MP, Miaskowski C, Dodd M. Relationship between fatigue and quality of life in patients with glioblastoma multiformae. Oncol Nurs Forum. 1999;26(5):921\u20135.","journal-title":"Oncol Nurs Forum"},{"issue":"3","key":"1411_CR39","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11060-016-2259-x","volume":"130","author":"N Alshehri","year":"2016","unstructured":"Alshehri N, Cote DJ, Hulou MM, Alghamdi A, Alshahrani A, Mekary RA, et al. Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis. J Neurooncol. 2016;130(3):561\u201370.","journal-title":"J Neurooncol"},{"issue":"4","key":"1411_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/neuonc\/2.4.221","volume":"2","author":"D Osoba","year":"2000","unstructured":"Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol. 2000;2(4):221\u20138.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1411_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11060-008-9738-7","volume":"92","author":"K Struik","year":"2009","unstructured":"Struik K, Klein M, Heimans JJ, Gielissen MF, Bleijenberg G, Taphoorn MJ, et al. Fatigue in low-grade glioma. J Neurooncol. 2009;92(1):73\u20138.","journal-title":"J Neurooncol"},{"issue":"11","key":"1411_CR42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","volume":"8","author":"B Seruga","year":"2008","unstructured":"Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8(11):887\u201399.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"1411_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2217\/cns-2015-0008","volume":"5","author":"A Asher","year":"2016","unstructured":"Asher A, Fu JB, Bailey C, Hughes JK. Fatigue among patients with brain tumors. CNS Oncol. 2016;5(2):91\u2013100.","journal-title":"CNS Oncol"},{"key":"1411_CR44","doi-asserted-by":"publisher","first-page":"110766","DOI":"10.1016\/j.jpsychores.2022.110766","volume":"156","author":"WM Kitselaar","year":"2022","unstructured":"Kitselaar WM, de Morree HM, Trompenaars MW, Sitskoorn MM, Rutten GJ, Kop WJ. Fatigue after neurosurgery in patients with a brain tumor: the role of autonomic dysregulation and disturbed sleep. J Psychosom Res. 2022;156:110766.","journal-title":"J Psychosom Res"},{"issue":"1","key":"1411_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.radonc.2011.06.028","volume":"100","author":"C Powell","year":"2011","unstructured":"Powell C, Guerrero D, Sardell S, Cumins S, Wharram B, Traish D, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 2011;100(1):131\u20136.","journal-title":"Radiother Oncol"},{"issue":"8","key":"1411_CR46","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jcem.87.8.8751","volume":"87","author":"HL Muller","year":"2002","unstructured":"Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N. Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab. 2002;87(8):3993\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"1411_CR47","doi-asserted-by":"publisher","first-page":"iv65","DOI":"10.1093\/neuonc\/nos210","volume":"14","author":"TS Armstrong","year":"2012","unstructured":"Armstrong TS, Gilbert MR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro Oncol. 2012;14(Suppl 4):iv65\u201372.","journal-title":"Neuro Oncol"},{"key":"1411_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1188\/14.CJON.S3.38-58","volume":"18","author":"SA Mitchell","year":"2014","unstructured":"Mitchell SA, Hoffman AJ, Clark JC, DeGennaro RM, Poirier P, Robinson CB, et al. Putting evidence into practice: an update of evidence-based interventions for cancer-related fatigue during and following treatment. Clin J Oncol Nurs. 2014;18:38\u201358.","journal-title":"Clin J Oncol Nurs"},{"key":"1411_CR49","doi-asserted-by":"publisher","first-page":"101083","DOI":"10.1016\/j.conctc.2023.101083","volume":"32","author":"AR Loughan","year":"2023","unstructured":"Loughan AR, Lanoye A, Willis KD, Ravyts SG, Fox A, Zukas A, et al. Study protocol for cognitive behavioral therapy for insomnia in patients with primary brain tumor: A single-arm phase 2a proof-of-concept trial. Contemp Clin Trials Commun. 2023;32:101083.","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"1411_CR50","first-page":"CD006953","volume":"2009","author":"MM Goedendorp","year":"2009","unstructured":"Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Psychosocial interventions for reducing fatigue during cancer treatment in adults. Cochrane Database Syst Rev. 2009;2009(1):CD006953.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1411_CR51","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1037\/a0012825","volume":"134","author":"M Kangas","year":"2008","unstructured":"Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134(5):700\u201341.","journal-title":"Psychol Bull"},{"issue":"11","key":"1411_CR52","first-page":"CD006145","volume":"11","author":"F Cramp","year":"2012","unstructured":"Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11(11):CD006145.","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"1411_CR53","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1002\/cncr.25083","volume":"116","author":"P Jean-Pierre","year":"2010","unstructured":"Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a university of Rochester Cancer center community clinical oncology program research base study. Cancer. 2010;116(14):3513\u201320.","journal-title":"Cancer"},{"issue":"5","key":"1411_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1089\/jpm.2008.0230","volume":"12","author":"L Blackhall","year":"2009","unstructured":"Blackhall L, Petroni G, Shu J, Baum L, Farace E. A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med. 2009;12(5):433\u20139.","journal-title":"J Palliat Med"},{"issue":"18","key":"1411_CR55","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","volume":"32","author":"A Spathis","year":"2014","unstructured":"Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol. 2014;32(18):1882\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1411_CR56","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jamaoncol.2021.5948","volume":"8","author":"AB Porter","year":"2022","unstructured":"Porter AB, Liu H, Kohli S, Cerhan JL, Sloan J, McMurray RP, et al. Efficacy of treatment with Armodafinil for Cancer-Related fatigue in patients with High-grade glioma: A phase 3 randomized clinical trial. JAMA Oncol. 2022;8(2):259\u201367.","journal-title":"JAMA Oncol"},{"issue":"5","key":"1411_CR57","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jpainsymman.2020.05.023","volume":"60","author":"L Pedersen","year":"2020","unstructured":"Pedersen L, Lund L, Petersen MA, Sjogren P, Groenvold M. Methylphenidate as needed for fatigue in patients with advanced cancer. A prospective, Double-Blind, and Placebo-Controlled study. J Pain Symptom Manage. 2020;60(5):992\u20131002.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"1411_CR58","doi-asserted-by":"publisher","first-page":"e84391","DOI":"10.1371\/journal.pone.0084391","volume":"9","author":"S Gong","year":"2014","unstructured":"Gong S, Sheng P, Jin H, He H, Qi E, Chen W, et al. Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis. PLoS ONE. 2014;9(1):e84391.","journal-title":"PLoS ONE"},{"issue":"3","key":"1411_CR59","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/bmjspcare-2021-003244","volume":"13","author":"R Chow","year":"2023","unstructured":"Chow R, Bruera E, Sanatani M, Chiu L, Prsic E, Boldt G, et al. Cancer-related fatigue-pharmacological interventions: systematic review and network meta-analysis. BMJ Support Palliat Care. 2023;13(3):274\u201380.","journal-title":"BMJ Support Palliat Care"},{"issue":"23","key":"1411_CR60","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2010.28.1444","volume":"28","author":"AR Moraska","year":"2010","unstructured":"Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, et al. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North central Cancer treatment group NCCTG-N05C7 trial. J Clin Oncol. 2010;28(23):3673\u20139.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1411_CR61","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/bmjspcare-2020-002454","volume":"12","author":"C Centeno","year":"2022","unstructured":"Centeno C, Roji R, Portela MA, De Santiago A, Cuervo MA, Ramos D, et al. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo. BMJ Support Palliat Care. 2022;12(2):226\u201334.","journal-title":"BMJ Support Palliat Care"},{"issue":"Suppl 3","key":"1411_CR62","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1007\/s10072-004-0274-8","volume":"25","author":"A Boiardi","year":"2004","unstructured":"Boiardi A, Salmaggi A, Eoli M, Lamperti E, Silvani A. Headache in brain tumours: a symptom to reappraise critically. Neurol Sci. 2004;25(Suppl 3):S143\u20137.","journal-title":"Neurol Sci"},{"key":"1411_CR63","unstructured":"Follett KA. Neurosurgical pain management. Philadelphia: Saunders; 2004. xiv, 287 p. p."},{"issue":"3","key":"1411_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1023\/A:1006486423827","volume":"62","author":"T Fokstuen","year":"2000","unstructured":"Fokstuen T, Wilking N, Rutqvist LE, Wolke J, Liedberg A, Signomklao T, et al. Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res Treat. 2000;62(3):211\u20136.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1411_CR65","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-J","volume":"45","author":"RJ Carella","year":"1980","unstructured":"Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group brain metastases study I and II. Cancer. 1980;45(4):679\u201383.","journal-title":"Cancer"},{"key":"1411_CR66","doi-asserted-by":"crossref","unstructured":"Sierko E, Hempel D, Zuzda K, Wojtukiewicz MZ. Personalized radiation therapy in Cancer pain management. Cancers (Basel). 2019;11(3).","DOI":"10.3390\/cancers11030390"},{"key":"1411_CR67","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3389\/fonc.2018.00641","volume":"8","author":"RA El Shafie","year":"2018","unstructured":"El Shafie RA, Bohm K, Weber D, Lang K, Schlaich F, Adeberg S, et al. Palliative radiotherapy for leptomeningeal Carcinomatosis-Analysis of outcome, prognostic factors, and symptom response. Front Oncol. 2018;8:641.","journal-title":"Front Oncol"},{"key":"1411_CR68","first-page":"34","volume":"12","author":"T Saito","year":"2018","unstructured":"Saito T, Tomitaka E, Toya R, Matsuyama T, Ninomura S, Watakabe T, et al. A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective observational study. Clin Transl Radiat Oncol. 2018;12:34\u20139.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"6","key":"1411_CR69","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/cen.12314","volume":"79","author":"I Kreitschmann-Andermahr","year":"2013","unstructured":"Kreitschmann-Andermahr I, Siegel S, Weber Carneiro R, Maubach JM, Harbeck B, Brabant G. Headache and pituitary disease: a systematic review. Clin Endocrinol (Oxf). 2013;79(6):760\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1411_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.64.1.25","volume":"64","author":"I Favier","year":"2007","unstructured":"Favier I, van Vliet JA, Roon KI, Witteveen RJ, Verschuuren JJ, Ferrari MD, et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol. 2007;64(1):25\u201331.","journal-title":"Arch Neurol"},{"issue":"Pt 8","key":"1411_CR71","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/brain\/awh525","volume":"128","author":"MJ Levy","year":"2005","unstructured":"Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005;128(Pt 8):1921\u201330.","journal-title":"Brain"},{"key":"1411_CR72","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","DOI":"10.1177\/0333102417738202"},{"issue":"5","key":"1411_CR73","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/head.12563","volume":"55","author":"PA Rocha-Filho","year":"2015","unstructured":"Rocha-Filho PA. Post-craniotomy headache: a clinical view with a focus on the persistent form. Headache. 2015;55(5):733\u20138.","journal-title":"Headache"},{"issue":"2","key":"1411_CR74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1227\/01.NEU.0000372092.96124.E6","volume":"67","author":"P Goffaux","year":"2010","unstructured":"Goffaux P, Fortin D. Brain tumor headaches: from bedside to bench. Neurosurgery. 2010;67(2):459\u201366.","journal-title":"Neurosurgery"},{"issue":"5","key":"1411_CR75","first-page":"491","volume":"14","author":"DA Schessel","year":"1993","unstructured":"Schessel DA, Rowed DW, Nedzelski JM, Feghali JG. Postoperative pain following excision of acoustic neuroma by the suboccipital approach: observations on possible cause and potential amelioration. Am J Otol. 1993;14(5):491\u20134.","journal-title":"Am J Otol"},{"key":"1411_CR76","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jocn.2018.04.003","volume":"52","author":"A Sabab","year":"2018","unstructured":"Sabab A, Sandhu J, Bacchi S, Jukes A, Zacest A. Postoperative headache following treatment of vestibular Schwannoma: A literature review. J Clin Neurosci. 2018;52:26\u201331.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"1411_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1177\/019459989210700314","volume":"107","author":"DA Schessel","year":"1992","unstructured":"Schessel DA, Nedzelski JM, Rowed D, Feghali JG. Pain after surgery for acoustic neuroma. Otolaryngol Head Neck Surg. 1992;107(3):424\u20139.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"1411_CR78","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1526-4610.2003.03053.x","volume":"43","author":"JR Gee","year":"2003","unstructured":"Gee JR, Ishaq Y, Vijayan N. Postcraniotomy headache. Headache. 2003;43(3):276\u20138.","journal-title":"Headache"},{"issue":"7","key":"1411_CR79","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2044.2005.03997.x","volume":"60","author":"LC de Gray","year":"2005","unstructured":"de Gray LC, Matta BF. Acute and chronic pain following craniotomy: a review. Anaesthesia. 2005;60(7):693\u2013704.","journal-title":"Anaesthesia"},{"key":"1411_CR80","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1016\/j.wneu.2019.01.262","volume":"125","author":"A Alwadei","year":"2019","unstructured":"Alwadei A, Almubarak AO, Bafaquh M, Qoqandi O, Alobaid A, Alsubaie F, et al. Supratentorial craniotomies with or without dural Closure-A comparison. World Neurosurg. 2019;125:e1132\u20137.","journal-title":"World Neurosurg"},{"issue":"10","key":"1411_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11916-018-0722-4","volume":"22","author":"B Lutman","year":"2018","unstructured":"Lutman B, Bloom J, Nussenblatt B, Romo V. A contemporary perspective on the management of Post-Craniotomy headache and pain. Curr Pain Headache Rep. 2018;22(10):69.","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"1411_CR82","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S1474-4422(09)70209-1","volume":"8","author":"N Bogduk","year":"2009","unstructured":"Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009;8(10):959\u201368.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1411_CR83","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1212\/WNL.0000000000012150","volume":"97","author":"SF Winter","year":"2021","unstructured":"Winter SF, Klein JP, Vaios EJ, Karschnia P, Lee EQ, Shih HA, et al. Clinical presentation and management of SMART syndrome. Neurology. 2021;97(3):118\u201320.","journal-title":"Neurology"},{"key":"1411_CR84","doi-asserted-by":"publisher","first-page":"e921795","DOI":"10.12659\/AJCR.921795","volume":"21","author":"RD Biju","year":"2020","unstructured":"Biju RD, Dower A, Moon BG, Gan P. SMART (Stroke-Like migraine attacks after radiation Therapy) syndrome: A case study with imaging supporting the theory of vascular dysfunction. Am J Case Rep. 2020;21:e921795.","journal-title":"Am J Case Rep"},{"issue":"15","key":"1411_CR85","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.4103\/0366-6999.161393","volume":"128","author":"Q Zheng","year":"2015","unstructured":"Zheng Q, Yang L, Tan LM, Qin LX, Wang CY, Zhang HN. Stroke-like migraine attacks after radiation therapy syndrome. Chin Med J (Engl). 2015;128(15):2097\u2013101.","journal-title":"Chin Med J (Engl)"},{"issue":"12","key":"1411_CR86","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3174\/ajnr.A3602","volume":"34","author":"DF Black","year":"2013","unstructured":"Black DF, Morris JM, Lindell EP, Krecke KN, Worrell GA, Bartleson JD, et al. Stroke-like migraine attacks after radiation therapy (SMART) syndrome is not always completely reversible: a case series. AJNR Am J Neuroradiol. 2013;34(12):2298\u2013303.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"1411_CR87","first-page":"184","volume":"1","author":"C Kamiya-Matsuoka","year":"2014","unstructured":"Kamiya-Matsuoka C, Cachia D, Olar A, Armstrong TS, Gilbert MR. Primary brain tumors and posterior reversible encephalopathy syndrome. Neurooncol Pract. 2014;1(4):184\u201390.","journal-title":"Neurooncol Pract"},{"issue":"9","key":"1411_CR88","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s12630-010-9350-0","volume":"57","author":"V Singh","year":"2010","unstructured":"Singh V, Sinha A, Prakash N. Ondansetron-induced migraine-type headache. Can J Anaesth. 2010;57(9):872\u20133.","journal-title":"Can J Anaesth"},{"key":"1411_CR89","unstructured":"Bevacizumab. Package insert."},{"key":"1411_CR90","unstructured":"Ondansetron. FDA package insert."},{"key":"1411_CR91","doi-asserted-by":"publisher","first-page":"116706","DOI":"10.1016\/j.jns.2020.116706","volume":"411","author":"JP Thakkar","year":"2020","unstructured":"Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV. Leptomeningeal metastasis from solid tumors. J Neurol Sci. 2020;411:116706.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1411_CR92","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/bjc.1995.513","volume":"72","author":"R Doll","year":"1995","unstructured":"Doll R. Hazards of ionising radiation: 100 years of observations on man. Br J Cancer. 1995;72(6):1339\u201349.","journal-title":"Br J Cancer"},{"issue":"2","key":"1411_CR93","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.rpor.2020.01.009","volume":"25","author":"M Fujii","year":"2020","unstructured":"Fujii M, Ichikawa M, Iwatate K, Bakhit M, Yamada M, Kuromi Y, et al. Secondary brain tumors after cranial radiation therapy: A single-institution study. Rep Pract Oncol Radiother. 2020;25(2):245\u20139.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"4","key":"1411_CR94","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.adro.2022.100969","volume":"7","author":"EK Liu","year":"2022","unstructured":"Liu EK, Oh C, Kondziolka D, Sulman EP. Risk of second primary neoplasms of the central nervous system. Adv Radiat Oncol. 2022;7(4):100969.","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"1411_CR95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer RJ, Zhou T, Holmes E, Vezina G, Gajjar A. Survival and secondary tumors in children with Medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of children\u2019s oncology group trial A9961. Neuro Oncol. 2013;15(1):97\u2013103.","journal-title":"Neuro Oncol"},{"issue":"8","key":"1411_CR96","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/ijc.28991","volume":"135","author":"DK Choi","year":"2014","unstructured":"Choi DK, Helenowski I, Hijiya N. Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature. Int J Cancer. 2014;135(8):1764\u201373.","journal-title":"Int J Cancer"},{"issue":"6","key":"1411_CR97","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","volume":"100","author":"AK Ng","year":"2002","unstructured":"Ng AK, Bernardo MV, Weller E, Backstrand K, Silver B, Marcus KC, et al. Second malignancy after hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002;100(6):1989\u201396.","journal-title":"Blood"},{"issue":"10","key":"1411_CR98","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/cncr.20253","volume":"100","author":"A Broniscer","year":"2004","unstructured":"Broniscer A, Ke W, Fuller CE, Wu J, Gajjar A, Kun LE. Second neoplasms in pediatric patients with primary central nervous system tumors: the St. Jude children\u2019s research hospital experience. Cancer. 2004;100(10):2246\u201352.","journal-title":"Cancer"},{"issue":"5","key":"1411_CR99","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jnci\/djh058","volume":"96","author":"O Fletcher","year":"2004","unstructured":"Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004;96(5):357\u201363.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1411_CR100","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/jnci\/90.8.606","volume":"90","author":"M Hisada","year":"1998","unstructured":"Hisada M, Garber JE, Fung CY, Fraumeni JF Jr., Li FP. Multiple primary cancers in families with Li-Fraumeni syndrome. J Natl Cancer Inst. 1998;90(8):606\u201311.","journal-title":"J Natl Cancer Inst"},{"issue":"32","key":"1411_CR101","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1200\/JCO.19.00114","volume":"37","author":"S Bhatia","year":"2019","unstructured":"Bhatia S, Chen Y, Wong FL, Hageman L, Smith K, Korf B, et al. Subsequent neoplasms after a primary tumor in individuals with neurofibromatosis type 1. J Clin Oncol. 2019;37(32):3050\u20138.","journal-title":"J Clin Oncol"},{"issue":"13","key":"1411_CR102","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/jnci\/djp148","volume":"101","author":"GT Armstrong","year":"2009","unstructured":"Armstrong GT, Liu Q, Yasui Y, Huang S, Ness KK, Leisenring W, et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood Cancer survivor study. J Natl Cancer Inst. 2009;101(13):946\u201358.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1411_CR103","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1210\/jc.2004-1152","volume":"90","author":"G Minniti","year":"2005","unstructured":"Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Risk of second brain tumor after Conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2005;90(2):800\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1411_CR104","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2213-8587(22)00160-7","volume":"10","author":"R Hamblin","year":"2022","unstructured":"Hamblin R, Vardon A, Akpalu J, Tampourlou M, Spiliotis I, Sbardella E, et al. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol. 2022;10(8):581\u20138.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"21","key":"1411_CR105","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djj411","volume":"98","author":"JP Neglia","year":"2006","unstructured":"Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood Cancer survivor study. J Natl Cancer Inst. 2006;98(21):1528\u201337.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1411_CR106","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1038\/s41598-020-66328-8","volume":"10","author":"R Fric","year":"2020","unstructured":"Fric R, Due-Tonnessen BJ, Lundar T, Egge A, Kronen Krossnes B, Due-Tonnessen P, et al. Long-term outcome of posterior fossa Medulloblastoma in patients surviving more than 20 years following primary treatment in childhood. Sci Rep. 2020;10(1):9371.","journal-title":"Sci Rep"},{"issue":"1","key":"1411_CR107","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1470-2045(18)30659-4","volume":"20","author":"A Wolf","year":"2019","unstructured":"Wolf A, Naylor K, Tam M, Habibi A, Novotny J, Liscak R, et al. Risk of radiation-associated intracranial malignancy after stereotactic radiosurgery: a retrospective, multicentre, cohort study. Lancet Oncol. 2019;20(1):159\u201364.","journal-title":"Lancet Oncol"},{"issue":"2","key":"1411_CR108","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-021-03761-3","volume":"153","author":"CS Gillespie","year":"2021","unstructured":"Gillespie CS, Islim AI, Taweel BA, Millward CP, Kumar S, Rathi N, et al. The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring. J Neurooncol. 2021;153(2):239\u201349.","journal-title":"J Neurooncol"},{"issue":"19","key":"1411_CR109","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1088\/0031-9155\/57\/19\/6047","volume":"57","author":"H Paganetti","year":"2012","unstructured":"Paganetti H, Athar BS, Moteabbed M, Schneider JAA, Yock U. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol. 2012;57(19):6047\u201361.","journal-title":"Phys Med Biol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01411-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T12:41:36Z","timestamp":1742733696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01411-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01411-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"28 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conflict of Interest: Jigisha Thakkar: No conflict of interest. Diego Luy: No conflict of interest. Andrew Pickles: No conflict of interest. Tamer Refaat: No conflict of interest. Vikram Prabhu: No conflict of interest. Human and Animal Rights and Informed consent: Article does not contain any studies with human or animal subject performed by any authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"26"}}